Device Apollo Revise System_endo

Apollo Revise System

Payments companies reported to CMS as associated with Apollo Revise System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$20Kassociated payments (2023-2025)
35clinicians with associated payments
1company reporting

By year

2023 $155
2024 $19K
2025 $1,318

Payments reported as associated with Apollo Revise System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $12K
Surgery $7,006
Pediatric Gastroenterology $380
Anesthesiology $171
Adult Health (Nurse Practitioner) $171
Internal Medicine $171

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Apollo Revise System

These are the largest totals companies reported as associated with Apollo Revise System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Adarsh Thaker Los Angeles, CA Gastroenterology (Internal Medicine) $9,325.73
Natan Zundel North Miami Beach, FL Surgery $6,500.00
Michael Mendoza Monterey, CA Gastroenterology (Internal Medicine) $478.42
Hawwa Alao Seattle, WA Gastroenterology (Internal Medicine) $439.61
Travis Piester Seattle, WA Pediatric Gastroenterology $380.07
Halim Charbel Germantown, MD Gastroenterology (Internal Medicine) $182.06
Ali Siddiqui Fairfax, VA Gastroenterology (Internal Medicine) $171.12
Aaron Sachs Baltimore, MD Anesthesiology $171.12
Reza Hashemipour Germantown, MD Gastroenterology (Internal Medicine) $171.12
Kristen Koller Washington, DC Adult Health (Nurse Practitioner) $171.12

Prescribed Apollo Revise System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.